Literature DB >> 8916956

Role of interleukin-2 (IL-2), IL-7, and IL-15 in natural killer cell differentiation from cord blood hematopoietic progenitor cells and from gamma c transduced severe combined immunodeficiency X1 bone marrow cells.

M Cavazzana-Calvo1, S Hacein-Bey, G de Saint Basile, C De Coene, F Selz, F Le Deist, A Fischer.   

Abstract

Natural killer (NK) cells are characterized by their ability to mediate spontaneous cytotoxicity against susceptible tumor cells and infected cells. They differentiate from hematopoietic progenitor cells. Patients with X-linked severe combined immunodeficiency (SCID X1) carry mutations in the gamma c cytokine receptor gene that result in lack of both T and NK cells. To assess the role of interleukin-2 (IL-2), IL-7, and IL-15 cytokines, which share gamma c receptor subunit, in NK cell differentiation, we have studied NK cell differentiation from cord blood CD34 (+) cells in the presence of either stem cell factor (SCF), IL-2, and IL-7 or SCF and IL-15. The former cytokine combination efficiently induced CD34 (+) CD7 (+) cord blood cells to proliferate and mature into NK cells, while the latter was also able to induce NK cell differentiation from more immature CD34 (+) CD7 (-) cord blood cells. NK cells expressed CD56 and efficiently killed K562 target cells. These results show that IL-15 could play an important role in the maturation of NK cell from cord blood progenitors. Following retroviral-mediated gene transfer of gamma c into SCID X1 bone marrow progenitors, it was possible to reproduce a similar pattern of NK cell differentiation in two SCID-X1 patients with SCF + IL-2 + IL-7 and more efficiently in one of them with SCF + IL-15. These results strongly suggest that the gamma c chain transduces major signal(s) involved in NK cell differentiation from hematopoietic progenitor cells and that IL-15 interaction with gamma c is involved in this process at an earlier step than IL-2/IL-7 interactions of gamma c are. It also shows that gene transfer into hematopoietic progenitor cells could potentially restore NK cell differentiation in SCID X1 patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8916956

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  19 in total

Review 1.  Primary T-lymphocyte immunodeficiencies.

Authors:  A Fischer
Journal:  Clin Rev Allergy Immunol       Date:  2001-02       Impact factor: 8.667

Review 2.  Severe combined immunodeficiencies (SCID).

Authors:  A Fischer
Journal:  Clin Exp Immunol       Date:  2000-11       Impact factor: 4.330

3.  A self-inactivating lentiviral vector for SCID-X1 gene therapy that does not activate LMO2 expression in human T cells.

Authors:  Sheng Zhou; Disha Mody; Suk See DeRavin; Julia Hauer; Taihe Lu; Zhijun Ma; Salima Hacein-Bey Abina; John T Gray; Michael R Greene; Marina Cavazzana-Calvo; Harry L Malech; Brian P Sorrentino
Journal:  Blood       Date:  2010-05-10       Impact factor: 22.113

Review 4.  Gene therapy of X-linked severe combined immunodeficiency.

Authors:  Salima Hacein-Bey-Abina; Alain Fischer; Marina Cavazzana-Calvo
Journal:  Int J Hematol       Date:  2002-11       Impact factor: 2.490

5.  Lymphomagenesis in SCID-X1 mice following lentivirus-mediated phenotype correction independent of insertional mutagenesis and gammac overexpression.

Authors:  Samantha L Ginn; Sophia H Y Liao; Allison P Dane; Min Hu; Jessica Hyman; John W Finnie; Maolin Zheng; Marina Cavazzana-Calvo; Stephen I Alexander; Adrian J Thrasher; Ian E Alexander
Journal:  Mol Ther       Date:  2010-03-30       Impact factor: 11.454

Review 6.  Gene therapy of primary immunodeficiencies.

Authors:  F Candotti; R M Blaese
Journal:  Springer Semin Immunopathol       Date:  1998

Review 7.  Severe combined immune deficiencies due to defects of the common gamma chain-JAK3 signaling pathway.

Authors:  F Candotti; J J O'Shea; A Villa
Journal:  Springer Semin Immunopathol       Date:  1998

8.  IL2rg Cytokines Enhance Umbilical Cord Blood CD34+ Cells Differentiation to T Cells.

Authors:  Zeynab Aliyari; Sara Soleimanirad; Manizheh Sayyah Melli; Hamid Tayefi Nasrabadi; Hojjatollah Nozad Charoudeh
Journal:  Adv Pharm Bull       Date:  2015-12-31

Review 9.  JAK/STAT signaling in regulation of innate lymphoid cells: The gods before the guardians.

Authors:  Helena Stabile; Gianluca Scarno; Cinzia Fionda; Angela Gismondi; Angela Santoni; Massimo Gadina; Giuseppe Sciumè
Journal:  Immunol Rev       Date:  2018-11       Impact factor: 12.988

Review 10.  Inborn errors of the development of human natural killer cells.

Authors:  Emmanuelle Jouanguy; Laure Gineau; Julien Cottineau; Vivien Béziat; Eric Vivier; Jean-Laurent Casanova
Journal:  Curr Opin Allergy Clin Immunol       Date:  2013-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.